Pacemaker Market 2022 | Market Growth, Opportunities, and Forecast to 2028
Pacemaker
Market is projected to reach USD 5.7 Billion in 2027 and expected to
register a 2.8% CAGR during the forecast period. Surging prevalence of cardiovascular
diseases across the globe is the prime drive behind the growth of the global Pacemaker
Market. A pacemaker is used in the management of atrial fibrillation, to
maintain adequate heart rate. Increasing global geriatric remains a significant
growth driver.
Competitive Landscape
Global manufacturers of pacemaker’s market include
Biotronik GmbH & Co. KG (Germany), Medtronic Plc
(U.S.), Sorin Group, St. Jude Medical Inc. (U.S.), Edwards Lifesciences (U.S.),
ATS Medical (U.S.), Vitatron Holding B.V. (the Netherlands), Zoll Medical
Corporation (U.S.), and
The old age population is more prone to developing cardiac
disorders and subsequently boosting the growth of the global pacemaker market.
Technological advancements in the pacemaker arena have resulted in the
development of improved pacemakers with extended battery life, smaller size,
better performance, and reduced failure rate. Leadless pacemakers are the new
addition to the pacemaker space. They are typically the size of a pill and can
be implanted with a minimally invasive procedure. Other driving factors include
raising awareness regarding cardiovascular disorders and the general decline in
the prices of pacemakers and treatment procedures. The rise in a number of FDA
approval for new pacemakers can also be credited for the growth of the market.
On the contrary, the growth of the global pacemaker market might be hindered
due to the high costs associated with pacemakers which limit market growth in
price-sensitive markets. Post-implantation complications of pacemakers are also
possible bottlenecks to the growth of the global Pacemaker Market. The market
growth is also at a threat from alternative treatment options.
Segmentation
The pacemaker market has been segmented based on product
type, application, implant approach, and end user.
·
By product type, the global pacemaker
market has been segmented into implantable, and external. The implantable
segment has been segmented into single chamber, dual chamber, and
biventricular.
·
By application, the global pacemaker
market has been segmented into syncope, hypertrophic cardiomyopathy,
bradycardia, and heart failure. The bradycardia segment has been further
segmented into sinus node dysfunction and AV block.
·
By implant approach, the global pacemaker
market has been segmented into endocardial approach and epicardial approach.
·
By end user, the global pacemaker market
has been segmented into hospitals & clinics, ambulatory surgical centers,
research & academic institutes, and others.
·
Boston Scientific Corporation (U.S.).
Regional Analysis
Geographically, the global pacemaker market has been
segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East
& Africa (MEA).
The Americas
pacemaker market has been segmented into North America and South
America. The Americas is at the forefront of the global pacemaker market due to
the high prevalence of cardiovascular disorders in the region which induces
greater demand for pacemakers. The region tends to adopt advanced technologies
swiftly which coupled with higher affordability drives the market in the
Americas.
Europe is the second largest market for a pacemaker. The
Europe market is driven by government funding for R&D and the presence of
leading market participants in the regions. APAC is slated to be the fastest
growing market over the forecast period. The MEA market is likely to exhibit
the lowest growth due to limited development in the medical field, lack of
technical knowledge, and poor medical facilities.
Industry Updates
December 2018- Carondelet St. Joseph’s Hospital in Tucson,
the US is now offering a leadless pacemaker which can be implanted through a minimally
invasive surgical procedure. The pacemaker can be used to treat patients with
irregular or slower-than-normal heart rate. The new pacemaker is about the size
of a vitamin pill and does not require cardiac wires.
Related Report-
Global
Body Contouring Market Research Report- Forecast To 2027
Global
Erythropoietin Drug Market Research Report- Forecast To 2027
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New York
10013
Comments
Post a Comment